aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
martes, 17 de febrero de 2026
Town Hall – Clinical Decision Support Software, Final Guidance March 11, 2026
https://www.fda.gov/medical-devices/medical-devices-news-and-events/town-hall-clinical-decision-support-software-final-guidance-03112026?utm_medium=email&utm_source=govdelivery
The U.S. Food and Drug Administration (FDA) will host a town hall for industry and other interested parties to discuss updates to the Clinical Decision Support Software, Final Guidance, issued on January 6, 2026, and re-issued on January 29, 2026.
This guidance clarifies the FDA’s thinking on the types of clinical decision support (CDS) software functions that are excluded from the definition of device by the criteria in section 520(o)(1)(E) of the Federal Food, Drug, and Cosmetic Act. This guidance further clarifies that the FDA’s existing digital health policies continue to apply to software functions that meet the definition of device, including those that are intended for use by patients or caregivers.
Dates: March 11, 2026
Time: 1:00 – 2:00 p.m. ET
Registration is not required.
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software?utm_medium=email&utm_source=govdelivery
Clinical Decision Support Software
Guidance for Industry and Food and Drug Administration Staff
January 2026
No hay comentarios:
Publicar un comentario